Growth hormone deficiency and Bedwetting
Summary:
Bedwetting is found among people with Growth hormone deficiency, especially for people who are male, 2-9 old.
The study analyzes which people have Bedwetting with Growth hormone deficiency. It is created by eHealthMe based on reports of 42 people who have Growth hormone deficiency from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Growth hormone deficiency?
Growth hormone deficiency is found to be associated with 47 drugs and 221 conditions by eHealthMe. Check the latest studies of Growth hormone deficiency.
What is Bedwetting?
Bedwetting is found to be associated with 473 drugs and 862 conditions by eHealthMe. Check the latest studies of Bedwetting.
42 people who have Growth Hormone Deficiency and Bedwetting are studied.

Gender of people who have Growth Hormone Deficiency and experienced Bedwetting *:
- female: 36.59 %
- male: 63.41 %
Age of people who have Growth Hormone Deficiency and experienced Bedwetting *:
- 0-1: 0.0 %
- 2-9: 47.83 %
- 10-19: 39.13 %
- 20-29: 0.0 %
- 30-39: 8.7 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 4.35 %
Common co-existing conditions for these people *:
- Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 5 people, 11.90%
- Body Height Below Normal: 3 people, 7.14%
- Constipation: 3 people, 7.14%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 4.76%
- Hypersensitivity: 2 people, 4.76%
- Small For Dates Baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age): 1 person, 2.38%
- Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 1 person, 2.38%
- Asthma: 1 person, 2.38%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 2.38%
- Bladder Spasm: 1 person, 2.38%
Common drugs taken by these people *:
- Nutropin Aq: 13 people, 30.95%
- Genotropin: 9 people, 21.43%
- Synthroid: 5 people, 11.90%
- Nutropin: 5 people, 11.90%
- Norditropin: 5 people, 11.90%
- Miralax: 3 people, 7.14%
- Tegretol: 3 people, 7.14%
- Ritalin: 3 people, 7.14%
- Lupron: 3 people, 7.14%
- Humatrope: 3 people, 7.14%
Common symptoms for these people *:
- Headache (pain in head): 9 people, 21.43%
- Weight Increased: 7 people, 16.67%
- Abnormal Behavior: 6 people, 14.29%
- Encopresis (inability to control the elimination of stool): 5 people, 11.90%
- Insulin-Like Growth Factor Increased: 5 people, 11.90%
- Visual Impairment: 4 people, 9.52%
- Nightmares (unpleasant dreams): 4 people, 9.52%
- Tic (a sudden, repetitive, nonrhythmic motor movement or vocalization involving discrete muscle groups): 4 people, 9.52%
- Injection Site Bruising: 3 people, 7.14%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Bedwetting?
- Check whether Bedwetting is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Growth hormone deficiency (21,584 reports)
- Bedwetting (6,093 reports)
All the drugs that are associated with Bedwetting:
- Bedwetting (473 drugs)
All the conditions that are associated with Bedwetting:
- Bedwetting (862 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Bedwetting and Growth hormone deficiency, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Perindopril Erbumine and Metoprolol Tartrate - now
- Could Lantus cause Sense Of Oppression? - 7 seconds ago
- Drug interactions of Mupirocin and Tamsulosin Hydrochloride - 11 seconds ago
- Could Lantus cause Infection? - 13 seconds ago
- Drug interactions of Lupron and Provera - 25 seconds ago
- Could Lantus cause Cardiac Failure? - 31 seconds ago
- Could Lantus cause Shock Haemorrhagic? - 44 seconds ago
- Drug interactions of Alprazolam and Erythromycin - 48 seconds ago
- Could Lantus cause Retinal Haemorrhage? - 51 seconds ago
- Drug interactions of Nicorette and Cephalexin - 55 seconds ago